Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAcademisch Ziekenhuis Maastricht
About this trial
The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET/CT. The main questions it aims to answer are:
* Is the new quantification method superior with respect to the method currently used in the clinic? * Does the new quantification method provide accurate assessment of the sugar consumption of tumours?
Participants who will undergo a standard care FDG PET/CT scan will in additional receive a dynamic PET/CT scan prior to the standard care scan. In addition blood samples will be drawn at three time points during the examination.
Eligibility criteria
Qualifiers
Patients who receive an 18F FDG PET/CT scan as part of standard care
Be competent and be 18 years of age or older
Disqualifiers
Diabetes (fasted blood glucose > 7 mmol/L)
Not fasted > 4 hours
Physical exercise within 24 hours
Earlier treatment for carcinoma with radio/chemo-therapy
Trial design
Treatments tested in this trial
- FDG PET/CT
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov